Status:
UNKNOWN
Hypertension and Cardiovascular Risk Associated With Obstructive Sleep Apnea in Adult in Guadeloupe (French West Indies)
Lead Sponsor:
Centre Hospitalier Universitaire de la Guadeloupe
Conditions:
Hypertension Arterial
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The MAPA is the reference method to estimate the PA during the SAHOS. The MAPA can be recommended over 48 hours: indeed, the PA falls at the beginning of every apnea then increases gradually up to a p...
Detailed Description
In Guadeloupe, data on the relationships between arterial hypertension and obstructive sleep apnea are unavailable. The aim of this study was: to assess the frequency of hypertension and non-dipper pa...
Eligibility Criteria
Inclusion
- Patient suspected of SAHOS;
- Patient or third-party responsible for receiving information on the study and who signed informed consent ;
- Patient age over 18 years; Patient living in Guadeloupe.
Exclusion
- Patient non-affiliated to the social security scheme ;
- Patient with obstructive bronchopneumopathy, neuro-muscular pathology,
- central and mixed SAS, cardiac arrhythmia,
- systemic and chronic inflammatory syndrome ; -
- Pregnant and lactating patient ;
- patient in emergency.
Key Trial Info
Start Date :
September 9 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT03373357
Start Date
September 9 2008
End Date
November 30 2019
Last Update
December 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital University Center of Pointe-à-Pitre
Pointe-à-Pitre, Guadeloupe, 97159